Literature DB >> 8315383

Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.

R M Chicz1, R G Urban, J C Gorga, D A Vignali, W S Lane, J L Strominger.   

Abstract

Naturally processed peptides were acid extracted from immunoaffinity-purified HLA-DR2, DR3, DR4, DR7, and DR8. Using the complementary techniques of mass spectrometry and Edman microsequencing, > 200 unique peptide masses were identified from each allele, ranging from 1,200 to 4,000 daltons (10-34 residues in length), and a total of 201 peptide sequences were obtained. These peptides were derived from 66 different source proteins and represented sets nested at both the amino- and carboxy-terminal ends with an average length of 15-18 amino acids. Strikingly, most of the peptides (> 85%) were derived from endogenous proteins that intersect the endocytic/class II pathway, even though class II molecules are thought to function mainly in the presentation of exogenous foreign peptide antigens. The predominant endogenous peptides were derived from major histocompatibility complex-related molecules. A few peptides derived from exogenous bovine serum proteins were also bound to every allele. Four prominent promiscuous self-peptide sets (capable of binding to multiple HLA-DR alleles) as well as 84 allele-specific peptide sets were identified. Binding experiments confirmed that the promiscuous peptides have high affinity for the binding groove of all HLA-DR alleles examined. A potential physiologic role for these endogenous self-peptides as immunomodulators of the cellular immune response is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8315383      PMCID: PMC2191090          DOI: 10.1084/jem.178.1.27

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  93 in total

1.  Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs.

Authors:  P Preston-Hurlburt; B K al-Ramadi; J Rothbard; C A Janeway
Journal:  Nature       Date:  1992-10-01       Impact factor: 49.962

2.  Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle.

Authors:  H C Guo; T S Jardetzky; T P Garrett; W S Lane; J L Strominger; D C Wiley
Journal:  Nature       Date:  1992-11-26       Impact factor: 49.962

3.  Atomic structure of a human MHC molecule presenting an influenza virus peptide.

Authors:  M L Silver; H C Guo; J L Strominger; D C Wiley
Journal:  Nature       Date:  1992-11-26       Impact factor: 49.962

4.  Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules.

Authors:  P A Roche; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

5.  Single amino acid changes in DR and antigen define residues critical for peptide-MHC binding and T cell recognition.

Authors:  J I Krieger; R W Karr; H M Grey; W Y Yu; D O'Sullivan; L Batovsky; Z L Zheng; S M Colón; F C Gaeta; J Sidney
Journal:  J Immunol       Date:  1991-04-01       Impact factor: 5.422

6.  A role for peptide in determining MHC class II structure.

Authors:  S Sadegh-Nasseri; R N Germain
Journal:  Nature       Date:  1991-09-12       Impact factor: 49.962

7.  MHC class II-restricted presentation of intracellular antigen.

Authors:  S Weiss; B Bogen
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

Review 8.  Interactions between immunogenic peptides and MHC proteins.

Authors:  J B Rothbard; M L Gefter
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

9.  Peripheral selection of the T cell repertoire.

Authors:  B Rocha; H von Boehmer
Journal:  Science       Date:  1991-03-08       Impact factor: 47.728

10.  Identification of a motif for HLA-DR1 binding peptides using M13 display libraries.

Authors:  J Hammer; B Takacs; F Sinigaglia
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

View more
  214 in total

1.  Characterization of the T cell recognition of hepatitis B surface antigen (HBsAg) by good and poor responders to hepatitis B vaccines.

Authors:  I Desombere; Y Gijbels; A Verwulgen; G Leroux-Roels
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

2.  Early endosomal maturation of MHC class II molecules independently of cysteine proteases and H-2DM.

Authors:  J A Villadangos; C Driessen; G P Shi; H A Chapman; H L Ploegh
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

3.  Presentation of cytosolic glycosylated peptides by human class I major histocompatibility complex molecules in vivo.

Authors:  J S Haurum; I B Høier; G Arsequell; A Neisig; G Valencia; J Zeuthen; J Neefjes; T Elliott
Journal:  J Exp Med       Date:  1999-07-05       Impact factor: 14.307

Review 4.  Molecular mimicry in autoimmune disease.

Authors:  S Leech
Journal:  Arch Dis Child       Date:  1998-11       Impact factor: 3.791

5.  Inhibition of allorecognition by a human class II MHC-derived peptide through the induction of apoptosis.

Authors:  B Murphy; C C Magee; S I Alexander; A M Waaga; H W Snoeck; J P Vella; C B Carpenter; M H Sayegh
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

Review 6.  Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51.

Authors:  H Direskeneli
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

7.  Functional mapping of protective domains and epitopes in the rotavirus VP6 protein.

Authors:  A H Choi; M Basu; M M McNeal; J Flint; J L VanCott; J D Clements; R L Ward
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

8.  Processing of glycans on glycoprotein and glycopeptide antigens in antigen-presenting cells.

Authors:  Ole Werdelin; Morten Meldal; Teis Jensen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-16       Impact factor: 11.205

9.  Lineage specificity of gene expression patterns.

Authors:  Yuval Kluger; David P Tuck; Joseph T Chang; Yasuhiro Nakayama; Ranjana Poddar; Naohiko Kohya; Zheng Lian; Abdelhakim Ben Nasr; H Ruth Halaban; Diane S Krause; Xueqing Zhang; Peter E Newburger; Sherman M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-19       Impact factor: 11.205

10.  LAMP-2-deficient human B cells exhibit altered MHC class II presentation of exogenous antigens.

Authors:  Victoria L Crotzer; Nicole Glosson; Delu Zhou; Ichizo Nishino; Janice S Blum
Journal:  Immunology       Date:  2010-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.